| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/14/2007 | WO2007067071A1 Dioxolane derivates for the treatment of cancer |
| 06/14/2007 | WO2007066755A1 Compound having hydrocoumarin skeleton, liquid crystal composition and liquid crystal display element |
| 06/14/2007 | WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof |
| 06/14/2007 | WO2007066181A2 Methods of preparing a vegf-r inhibitor |
| 06/14/2007 | WO2007066099A1 Pyrimidine derivatives |
| 06/14/2007 | WO2007065518A1 Pyridiazinone derivatives for tumour treatment |
| 06/14/2007 | WO2006126035A3 Process for the preparation of rosuvastatin |
| 06/14/2007 | WO2006099379A3 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 06/14/2007 | US20070135654 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING alpha-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME |
| 06/14/2007 | US20070135516 irciniastatins, essentially pure, isolated from Indo-Pacific marine sponge Ircinia ramosa by cancer cell line bioassay-guided techniques; isochromene-pyran derivatives; dichloromethane-methanol extract; anticarcinogenic agent; P388 lymphocytic leukemia and pancreas, breast, CNS, lung cancer cell lines |
| 06/14/2007 | US20070135508 e.g. (2(2S)-(1 alpha , 5 alpha , 6 alpha )-6-N-[3-benzyl-3-azabicyclo[3.1.0]-hexyl]-2-[(1R or 1S)-3-oxocyclohexyl]-2-hydroxy-2-phenylacetamide; respiratory, urinary and gastrointestinal systems disorder; antidiabetic agent |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135494 Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides |
| 06/14/2007 | US20070135492 Cannabinoid receptor 1 antagonists (CB1); use of 1,2,4-tri-substituted imidazoline derivatives in the treatment of obesity; use in combination with lipase inhibitor orlistat or lipstatin |
| 06/14/2007 | US20070135477 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/14/2007 | US20070135468 Pyridyloxyalkanoic acid amide derivatives useful as fungicides |
| 06/14/2007 | US20070135464 Antiinflammation agents |
| 06/14/2007 | US20070135442 Chroman compounds |
| 06/14/2007 | US20070135436 Chemical compounds |
| 06/14/2007 | US20070135433 Imidazole derivatives as raf kinase inhibitors |
| 06/14/2007 | US20070135428 Lactam containing cyclic diamines and derivatives as factor xa inhibitors |
| 06/14/2007 | US20070135422 Nitrogen-containing bicycle heterocycles for use as antibacterials |
| 06/14/2007 | US20070135402 Azetidine ring compounds and drugs comprising the same |
| 06/14/2007 | US20070135357 Anti-hypercholesterolemic compounds |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | US20070134161 Methods of determining beta-iii tubulin expression |
| 06/14/2007 | CA2632512A1 Bicyclic compounds with kinase inhibitory activity |
| 06/14/2007 | CA2632476A1 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| 06/14/2007 | CA2632384A1 Methods of preparing a vegf-r inhibitor |
| 06/14/2007 | CA2632280A1 Dioxolane derivates for the treatment of cancer |
| 06/14/2007 | CA2632217A1 Pyridiazinone derivatives for the treatment of tumours |
| 06/14/2007 | CA2631037A1 Bradykinin 1 receptor antagonists |
| 06/14/2007 | CA2630233A1 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors |
| 06/13/2007 | EP1795603A1 Process for synthesis of derivatives, compound library, method for making the mase, and screening method |
| 06/13/2007 | EP1795529A2 Process for producing N-(Hetero)Aryl-substituted nitrogen-containing heteroaryl compound |
| 06/13/2007 | EP1795526A1 N-substituted n-(4-piperidinyl)amide derivative |
| 06/13/2007 | EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors |
| 06/13/2007 | EP1794150A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands I |
| 06/13/2007 | EP1794145A1 Pyrazole compounds useful in the treatment of inflammation |
| 06/13/2007 | EP1794135A1 Substituted heterocyclic compounds and methods of use |
| 06/13/2007 | EP1794122A1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i |
| 06/13/2007 | EP1793826A2 Chemical compounds |
| 06/13/2007 | EP1641784B1 4-(aminomethyl)-piperidine benzamides as 5ht4 -antagonists |
| 06/13/2007 | EP1611122B1 Substituted pyrazole compounds |
| 06/13/2007 | EP1437353B1 Alkyl ether derivatives or salts thereof |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1000040B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/13/2007 | CN1980934A Novel indole derivatives as selective androgen receptor modulators (sarms) |
| 06/13/2007 | CN1980923A Polycyclic pyridines as potassium ion channel modulators |
| 06/13/2007 | CN1980918A Substituted indazoles, compositions containing the same, and the preparation and use thereof |
| 06/13/2007 | CN1980916A Chemokine receptor binding heterocyclic compounds |
| 06/13/2007 | CN1980899A Quinazolinone derivatives as parp inhibitors |
| 06/13/2007 | CN1980895A 1-aryl-4-substituted isoquinolines |
| 06/13/2007 | CN1980657A Novel antiviral helioxanthin analogs |
| 06/13/2007 | CN1978440A Process for producing N-(hetero)aryl-substituted nitrogen-containing heteroaryl compound |
| 06/13/2007 | CN1321116C Novel azepane derivatives |
| 06/12/2007 | US7230124 Prevent skin damage; therapy for skin disorders |
| 06/12/2007 | US7230116 For use as pesticides, microbicides and herbicides |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
| 06/12/2007 | US7230023 Triazole compound containing a phosphonate group |
| 06/12/2007 | US7230017 For therapy of neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230013 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth |
| 06/12/2007 | US7230010 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists |
| 06/12/2007 | US7229986 Melanin-concentrating hormone antagonist |
| 06/12/2007 | US7229576 Photochromic compounds derived from 2H-phenanthro[2,1-b]pyrans and 3H-phenanthro[3,4-b]pyrans, which in the open form have especially long wavelength absorption maxima, but in the unexcited state are still colorless, to their use in synthetic resin materials of all types, for ophthalmic purposes |
| 06/12/2007 | CA2300913C Novel compound 2-amino-3-[2-(.alpha.-mannopyranosyl)indol-3-yl]propionic acid, process for preparing the same, and method for inspecting function of living body with the novel compound |
| 06/12/2007 | CA2285445C 4-tetrahydropyridylpyrimidine derivative |
| 06/12/2007 | CA2130828C Non-azo naphthalimide dyes and uses for same |
| 06/07/2007 | WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007063986A1 Diaminoarylene compound having carbazolyl group and use thereof |
| 06/07/2007 | WO2007063925A1 2-aminobenzamide derivative |
| 06/07/2007 | WO2007063868A1 Arylmethylene urea derivative and use thereof |
| 06/07/2007 | WO2007063556A2 An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs |
| 06/07/2007 | WO2007063418A2 Substituted indole compounds having nos inhibitory activity |
| 06/07/2007 | WO2007063291A1 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors |
| 06/07/2007 | WO2007063010A1 Novel vinylogous acids derivatives |
| 06/07/2007 | WO2007057742A3 Novel piperazinone derivatives |
| 06/07/2007 | WO2007045420A3 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 06/07/2007 | WO2007043653A9 Benzimidazole-5-carboxamide derivative |
| 06/07/2007 | WO2007028132A3 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 06/07/2007 | WO2007002258A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 06/07/2007 | WO2006138350A3 Chemokine receptor binding compounds |
| 06/07/2007 | WO2006126939A8 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 06/07/2007 | WO2006081331A3 Quinoxaline derivatives as antitumor agents |
| 06/07/2007 | US20070129555 N,N'-Di(1-naphthyl)-N,N'-diphenyl-2,6-diaminodibenzodioxin; organic electroelement hole-transporting layer, light-emitting material, a host materialor dopant in the light-emitting layer,a hole-blocking layer, an electron-transporting layer;high luminous efficiency; high heat resistance; durability |
| 06/07/2007 | US20070129429 warfarin analogs with side effect reduction |
| 06/07/2007 | US20070129420 New pyrrolidinium derivatives |
| 06/07/2007 | US20070129413 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl) biphenyl derivatives |
| 06/07/2007 | US20070129400 Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity, and use thereof |
| 06/07/2007 | US20070129392 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 06/07/2007 | US20070129379 Hiv integrase inhibitors |
| 06/07/2007 | US20070129376 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129363 N-type calcium channel antagonists for the treatment of pain |
| 06/07/2007 | US20070129361 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS |
| 06/07/2007 | US20070129358 Sbstituted chroman derivatives, processes for their preparation and their use as antiinflammatory agents |